MassMutual Private Wealth & Trust FSB Sells 1,516 Shares of Stryker Co. (NYSE:SYK)

MassMutual Private Wealth & Trust FSB trimmed its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 2.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,641 shares of the medical technology company's stock after selling 1,516 shares during the quarter. MassMutual Private Wealth & Trust FSB's holdings in Stryker were worth $24,354,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in SYK. Purus Wealth Management LLC increased its position in Stryker by 6.6% during the 4th quarter. Purus Wealth Management LLC now owns 714 shares of the medical technology company's stock valued at $257,000 after purchasing an additional 44 shares during the period. AMI Investment Management Inc. increased its position in shares of Stryker by 11.8% during the fourth quarter. AMI Investment Management Inc. now owns 10,345 shares of the medical technology company's stock worth $3,725,000 after buying an additional 1,096 shares during the period. True Link Financial Advisors LLC bought a new position in Stryker during the fourth quarter worth $234,000. Trueblood Wealth Management LLC boosted its position in Stryker by 10.5% during the fourth quarter. Trueblood Wealth Management LLC now owns 3,140 shares of the medical technology company's stock valued at $1,131,000 after acquiring an additional 299 shares during the last quarter. Finally, Diversify Wealth Management LLC grew its holdings in Stryker by 4.2% during the 4th quarter. Diversify Wealth Management LLC now owns 9,205 shares of the medical technology company's stock worth $3,366,000 after acquiring an additional 373 shares during the period. 77.09% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Stryker

In other news, CEO Kevin Lobo sold 57,313 shares of Stryker stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $368.70, for a total value of $21,131,303.10. Following the completion of the transaction, the chief executive officer now owns 100,027 shares in the company, valued at $36,879,954.90. This trade represents a 36.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 5.90% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on SYK shares. Wells Fargo & Company upped their target price on Stryker from $405.00 to $427.00 and gave the company an "overweight" rating in a research report on Wednesday, December 11th. JMP Securities restated a "market perform" rating on shares of Stryker in a report on Tuesday, January 7th. StockNews.com upgraded shares of Stryker from a "hold" rating to a "buy" rating in a research note on Thursday, January 9th. Evercore ISI increased their target price on shares of Stryker from $380.00 to $384.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 30th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $420.00 price target (up from $380.00) on shares of Stryker in a research note on Wednesday, October 30th. Four equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $405.80.

Stryker Stock Performance

Shares of Stryker stock traded up $2.12 during mid-day trading on Monday, hitting $383.91. 1,727,106 shares of the stock were exchanged, compared to its average volume of 1,070,245. Stryker Co. has a 12 month low of $307.23 and a 12 month high of $398.20. The company has a 50-day simple moving average of $375.51 and a 200 day simple moving average of $359.17. The company has a market capitalization of $146.35 billion, a P/E ratio of 41.15, a P/E/G ratio of 2.51 and a beta of 0.95. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.22 and a current ratio of 1.91.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Tuesday, October 29th. The medical technology company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.77 by $0.10. The company had revenue of $5.49 billion for the quarter, compared to analysts' expectations of $5.37 billion. Stryker had a return on equity of 23.07% and a net margin of 16.34%. The business's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the previous year, the business posted $2.46 EPS. Sell-side analysts anticipate that Stryker Co. will post 12.06 earnings per share for the current fiscal year.

Stryker Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.84 dividend. This is an increase from Stryker's previous quarterly dividend of $0.80. This represents a $3.36 dividend on an annualized basis and a yield of 0.88%. The ex-dividend date is Tuesday, December 31st. Stryker's dividend payout ratio (DPR) is currently 36.01%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.